PEYRONIE'S DISEASE SYMPTOM BOTHER REDUCTION IS RELATED TO PENILE CURVATURE IMPROVEMENT IN RESPONSE TO TREATMENT WITH COLLAGENASE CLOSTRIDIUM HISTOLYTICUM: RESULTS FROM TWO LARGE DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED PHASE 3 STUDIES

被引：0

作者：

Lipshultz, L., I ^{[1
]}

Sadeghi-Nejad, H. ^{[2
]}

Mills, J. ^{[3
]}

Tursi, J. P. ^{[4
]}

Smith, T. M. ^{[4
]}

Kaufman, G. J. ^{[4
]}

Liu, G. ^{[4
]}

Honig, S. ^{[5
]}

机构：

[1] Baylor Coll Med, Houston, TX 77030 USA

[2] Ctr Male Reprod Med, Hackensack, NJ USA

[3] Urol Ctr Colorado, Denver, CO USA

[4] Auxilium Pharmaceut, Chesterbrook, PA USA

[5] Yale Univ, Sch Med, New Haven, CT USA

来源：

JOURNAL OF SEXUAL MEDICINE | 2015年 / 12卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

075

引用

页码：128 / 128

页数：1

共 50 条

[21] Collagenase Clostridium Histolyticum-aaes for the Treatment of Cellulite in Women: Results From Two Phase 3 Randomized, Placebo-Controlled Trials
Kaufman-Janette, Joely
Joseph, John H.
Kaminer, Michael S.
Clark, James
Fabi, Sabrina G.
Gold, Michael H.
Goldman, Mitchel P.
Katz, Bruce E.
Peddy, Kappa
Schlessinger, Joel
Young, V. Leroy
Davis, Matthew
Hurley, David
Liu, Genzhou
McLane, Michael P.
Vijayan, Saji
Bass, Lawrence S.
DERMATOLOGIC SURGERY, 2021, 47 (05) : 649 - 656
[22] Incremental Treatment Response by Cycle With Collagenase Clostridium Histolyticum for Peyronie's Disease: A Pooled Analysis of Two Phase 3 Trials
Ziegelmann, Matthew
Hu, Yiqun
Xiang, Qinfang
Liu, Genzhou
McLane, Michael P.
Trost, Landon
UROLOGY, 2023, 175 : 126 - 131
[23] Commentary on Collagenase Clostridium Histolyticum-Aaes for the Treatment of Cellulite in Women: Results From 2 Phase 3 Randomized, Placebo-Controlled Trials
Draelos, Zoe Diana
DERMATOLOGIC SURGERY, 2021, 47 (05) : 657 - 657
[24] INCREMENTAL TREATMENT RESPONSE BY CYCLE WITH COLLAGENASE CLOSTRIDIUM HISTOLYTICUM FOR PEYRONIE'S DISEASE: A POOLED ANALYSIS OF TWO PHASE 3 TRIALS
Ziegelmann, Matthew
Xiang, Qinfang
Hu, Yiqun
Trost, Landon
JOURNAL OF UROLOGY, 2022, 207 (05): : E409 - E410
[25] Phase 2a, randomized, double-blind, placebo-controlled dose-ranging study of repeat doses of collagenase clostridium histolyticum for the treatment of edematous fibrosclerotic panniculopathy (cellulite)
Goldman, Mitchel P.
Sadick, Neil S.
Young, Leroy
Kaufman, Gregory J.
Smith, Ted
Tursi, James P.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB19 - AB19
[26] Favipiravir Treatment of Uncomplicated Influenza in Adults: Results of Two Phase 3, Randomized, Double-Blind, Placebo-Controlled Trials
Hayden, Frederick G.
Lenk, Robert P.
Stonis, Lucille
Oldham-Creamer, Catherine
Kang, Lih Lisa
Epstein, Carol
JOURNAL OF INFECTIOUS DISEASES, 2022, 226 (10): : 1790 - 1799
[27] BRIVARACETAM IN PATIENTS WITH UNVERRICHT-LUNDBORG DISEASE: RESULTS FROM TWO RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND STUDIES
Kalviaiinen, R.
Genton, P.
Andermann, E.
Magaudda, A.
Frucht, S.
Schlit, A.
Gerard, D.
Van Otterdijk, E.
von Rosenstiel, P.
EPILEPSIA, 2009, 50 : 47 - 47
[28] Lamotrigine for treatment of pain associated with diabetic neuropathy: Results of two randomized, double-blind, placebo-controlled studies
Vinik, Aaron I.
Tuchman, Michael
Safirstein, Beth
Corder, Clinton
Kirby, Louis
Wilks, Kerri
Quessy, Steve
Blum, David
Grainger, Joanne
White, Jonathan
Silver, Marianne
PAIN, 2007, 128 (1-2) : 169 - 179
[29] Liposomal recombinant human superoxide dismutase for the treatment of Peyronie's disease:: A randomized placebo-controlled double-blind clinical study
Riedl, CR
Sternig, P
Langmann, F
Galle, G
Engelhardt, PF
Vcelar, B
Vorauer, K
Wagner, A
Katinger, H
Pflüger, H
JOURNAL OF UROLOGY, 2005, 173 (04): : 253 - 254
[30] Liposomal recombinant human superoxide dismutase for the treatment of Peyronie's disease: A randomized placebo-controlled double-blind clinical study
不详
EUROPEAN UROLOGY SUPPLEMENTS, 2005, 4 (03) : 219 - 219

← 1 2 3 4 5 →